Q4 2015 13F Holders as of 31 Dec 2015
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
27,795,576
-
Total 13F shares
-
13,599,931
-
Share change
-
+3,258,104
-
Total reported value
-
$290,948,310
-
Put/Call ratio
-
193%
-
Price per share
-
$21.49
-
Number of holders
-
93
-
Value change
-
+$71,230,645
-
Number of buys
-
56
-
Number of sells
-
26
Institutional Holders of Accelerate Diagnostics, Inc. - Common Stock, par value $0.001 per share (AXDX) as of Q4 2015
As of 31 Dec 2015,
Accelerate Diagnostics, Inc. - Common Stock, par value $0.001 per share (AXDX) was held by
93 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
13,599,931 shares.
The largest 10 holders included
Birchview Capital, LP, Miura Global Management, LLC, CANNELL PETER B & CO INC, VANGUARD GROUP INC, FIRST REPUBLIC INVESTMENT MANAGEMENT, INC., FMR LLC, BlackRock Institutional Trust Company, N.A., Nuveen Asset Management, LLC, BlackRock Fund Advisors, and Arrowpoint Asset Management, LLC.
This page lists
93
institutional shareholders reporting positions in this security
for the Q4 2015 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.